31 Dynamic change of PD-L1 expression on extracellular vesicles predicts response to immune-checkpoint inhibitors in non-small cell lung cancer patients

Similar Items

• Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
  by: Diego de Miguel-Perez, et al.
  Published: (2022-06-01)
• 23 Validation of PD-L1 dynamic expression on extracellular vesicles as a predictor of response to immune-checkpoint inhibitors and survival in non-small cell lung cancer patients
  by: Alessandro Russo, et al.
  Published: (2021-11-01)
• Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC
  by: Diego de Miguel‑Perez, et al.
  Published: (2024-03-01)
• Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients
  by: Adi Horesh, et al.
  Published: (2023-04-01)
• Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer
  by: Diego de Miguel-Perez, et al.
  Published: (2023-11-01)